SCHEMBL16359482

SCHEMBL16359482

CC[P@](C)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL191360 1.00
SCHEMBL19809605 0.96 CA2 (0.50)
SCHEMBL191058 0.96
SCHEMBL7714657 0.96
SCHEMBL22401612 0.96 CA2 (0.50)
SCHEMBL22401618 0.96 CA2 (0.50)
SCHEMBL190213 0.96
SCHEMBL17600691 0.96
SCHEMBL19809593 0.96 CA2 (0.50)
SCHEMBL28667992 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180179105-A1 METHOD FOR IMPREGNATING A FIBROUS SUBSTRATE WITH A METHACRYLIC MIXTURE COMPRISING A FLAME-RETARDANT SUBSTANCE ARKEMA FRANCE (FR) 2018-06-28 US disclosed
US-20180101098-A1 COATING AGENT FOR REDUCING ROUGHNESS OF RESIST PATTERN, AND METHOD FOR FORMING RESIST PATTERN IN WHICH ROUGHNESS IS REDUCED TOKYO OHKA KOGYO CO., LTD. (JP) 2018-04-12 US disclosed
US-20180079773-A1 PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS GILEAD SCIENCES, INC. 2018-03-22 US disclosed
US-9834710-B2 Adhesive compositions and methods SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2017-12-05 US disclosed
US-20170327520-A1 CONJUGATED BISPHOSPHONATES FOR THE DIAGNOSIS AND THERAPY OF BONE DISEASES SCV GMBH (DE) 2017-11-16 US disclosed
US-9783567-B2 Processes and intermediates for preparing anti-HIV agents GILEAD SCIENCES, INC. (US) 2017-10-10 US disclosed
EP-2355658-B1 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS ARBUTUS BIOPHARMA CORP (CA) 2017-09-27 EP disclosed
US-20170260219-A1 PHOSPHONATE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2017-09-14 US disclosed
US-20170152221-A1 ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF MERCK SHARP & DOHME CORP. (US) 2017-06-01 US disclosed
US-9663543-B2 Phosphonate compounds for treatment of complement mediated disorders ACHILLION PHARMACEUTICALS, INC. (US) 2017-05-30 US disclosed
US-20100000030-A1 PROCESS FOR THE FLAME-RETARDANT TREATMENT OF FIBER PRODUCTS HUNTSMAN TEXTILE EFFECTS ( GERMANY ) GMBH (US) 2010-01-07 US disclosed
EP-2105443-A1 Oxime derivatives and their use in photopolymerizable compositions for colour filters FUJIFILM Corporation (JP) 2009-09-30 EP disclosed
US-20090186343-A1 METHODS FOR PREPARING MODIFIED BIOMOLECULES, MODIFIED BIOMOLECULES AND METHODS FOR USING SAME VISIGEN BIOTECHNOLOGIES, INC. (US) 2009-07-23 US disclosed
US-20090050143-A1 MEDICINAL FORMULATION CONTAINER WITH A TREATED METAL SURFACE 3M INNOVATIVE PROPERTIES COMPANY 2009-02-26 US disclosed
US-7390595-B2 Method of preparing a crosslinked polymer in an electrolyte composition FUJIFILM CORPORATION (JP) 2008-06-24 US disclosed
US-20080132619-A1 Phosphorus-Containing Flame Retardant for Thermoplastic Polymers SUPRESTA LLC (US) 2008-06-05 US disclosed
US-7371852-B2 Alkyl-linked nucleotide compositions SERENEX, INC. (US) 2008-05-13 US disclosed
US-20080090803-A1 FATTY ALCOHOL DRUG CONJUGATES LUITPOLD PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed
US-7276598-B2 Phosphorylation reagents for improved processes to convert terminal hydroxyl groups of oligonucleotides into phosphate monoesters SIGMA-ALDRICH CO. (US) 2007-10-02 US disclosed
US-7208539-B2 Thermosetting resin composition, and prepreg and laminated board using the same HITACHI CHEMICAL CO., LTD. (JP) 2007-04-24 US disclosed